People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synlogic, Inc. | — | Biotechnology | Series C | $186.5M | $3.3B | 2014 |
| Spero Therapeutics, Inc. | — | Biotechnology | Series C | $92.2M | $150.5M | 2017 |
| Synlogic, LLC | — | Biotechnology | Series B | $31.0M | $679.3M | 2016 |
| Annovation BioPharma, Inc. | — | Pharmaceuticals | Series A | $10.4M | $247.8M | 2012 |
ANKIT MAHADEVIA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ANKIT MAHADEVIA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 2 | 18 |
| Jean-Francois Formela | 2 | 17 |
| Ed Mathers | 2 | 11 |
| Chau Khuong | 2 | 9 |
| Lewis Geffen | 2 | 6 |
| Jose Carlos Gutierrez-Ramos | 2 | 2 |
| Michael Powell | 1 | 14 |
| Scott Jackson | 1 | 13 |
| Corey Goodman | 1 | 13 |
| Edward Mathers | 1 | 12 |
| Elaine Jones | 1 | 6 |
| Daniel Geffken | 1 | 6 |
| David Grayzel | 1 | 6 |
| Casper Breum | 1 | 5 |
| Paul Miller | 1 | 5 |
| Nick Leschly | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| Evan S. Melrose | 1 | 5 |
| Corey S. Goodman | 1 | 4 |
| Milind Deshpande | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.